España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Milestone Pharmaceuticals
MIST
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$1.84
-0.01
-0.54%
At close: -
$1.85
0.01
0.55%
After Hours: 6:02 PM EDT
Get Report
Comment
Milestone Pharmaceuticals (MIST) Forecast
News
Earnings
Milestone Pharmaceuticals (MIST) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Milestone Pharmaceuticals (NASDAQ:MIST) Stock
Milestone Pharmaceuticals Stock (NASDAQ: MIST)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, November 12, 2024
Milestone Pharmaceuticals Q3 2024 GAAP EPS $(...
Benzinga Newsdesk
Monday, October 14, 2024
HC Wainwright & Co. Reiterates Buy on Milesto...
Benzinga Newsdesk
Friday, September 06, 2024
Milestone Says Licensing Partner Ji Xing Rele...
Benzinga Newsdesk
Thursday, August 22, 2024
HC Wainwright & Co. Reiterates Buy on Milesto...
Benzinga Newsdesk
Milestone Pharmaceuticals shares are trading ...
Benzinga Newsdesk
Rodman & Renshaw Initiates Coverage On Milest...
Benzinga Newsdesk
Thursday, August 08, 2024
Milestone Pharmaceuticals Q2 2024 Adj EPS $(0...
Benzinga Newsdesk
Monday, July 01, 2024
HC Wainwright & Co. Reiterates Buy on Milesto...
Benzinga Newsdesk
Thursday, May 30, 2024
HC Wainwright & Co. Reiterates Buy on Milesto...
Benzinga Newsdesk
Wednesday, May 29, 2024
FDA Accepts Milestone Pharmaceuticals' New Dr...
Benzinga Newsdesk
Thursday, May 16, 2024
Milestone Pharmaceuticals Upgraded to Buy: Here's What You Should Know
Zacks
HC Wainwright & Co. Reiterates Buy on Milesto...
Benzinga Newsdesk
Monday, May 13, 2024
Milestone Pharmaceuticals Says Cash Resources...
Benzinga Newsdesk
Milestone Pharmaceuticals Q1 2024 GAAP EPS $(...
Benzinga Newsdesk
Wednesday, April 17, 2024
Milestone Pharmaceuticals To Present Data On ...
Benzinga Newsdesk
Monday, April 08, 2024
Milestone Pharmaceuticals Announces Etripamil...
Benzinga Newsdesk
Monday, April 01, 2024
Milestone Pharmaceuticals To Present Data On ...
Benzinga Newsdesk
Thursday, March 28, 2024
Milestone Pharmaceuticals Disclosed Resubmiss...
Benzinga Newsdesk
Friday, March 22, 2024
HC Wainwright & Co. Reiterates Buy on Milesto...
Benzinga Newsdesk
Thursday, March 21, 2024
Milestone Pharmaceuticals: Q4 Earnings Insights
Benzinga Insights
Milestone Pharmaceuticals Q4 GAAP EPS $(0.32)...
Benzinga Newsdesk
Tuesday, March 05, 2024
Piper Sandler Maintains Overweight on Milesto...
Benzinga Newsdesk
Thursday, February 29, 2024
Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Avi Kapoor
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
Why Okta Shares Are Trading Higher By Around 24%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Milestone Pharmaceuticals Priced Its Public O...
Benzinga Newsdesk
Wednesday, February 28, 2024
Milestone Pharmaceuticals Announces Proposed ...
Benzinga Newsdesk
Monday, February 26, 2024
Why Freshpet Shares Are Trading Higher By Around 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Avi Kapoor
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on Milesto...
Benzinga Newsdesk
Why Milestone Pharmaceuticals (MIST) Stock Is Rising
Henry Khederian
Milestone Pharmaceuticals Plans To Resubmit T...
Benzinga Newsdesk
Tuesday, January 02, 2024
Top 5 Health Care Stocks That Could Lead To Your Biggest Gains in January
Avi Kapoor
Wednesday, December 27, 2023
Meta To Rally Over 18%? Here Are 10 Top Analyst Forecasts For Wednesday
Avi Kapoor
TD Cowen Maintains Outperform on Milestone Ph...
Benzinga Newsdesk
Tuesday, December 26, 2023
Nasdaq Surges 75 Points; Inspira Technologies Shares Spike Higher
Avi Kapoor
Why RayzeBio Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
Crude Oil Rises Over 3%; US Home Prices Increase In October
Avi Kapoor
Why Is Heart Disease-Focused Milestone Pharmaceuticals Stock Plummeting Today?
Vandana Singh
Dow Gains Over 50 Points; Chicago Fed National Activity Index Increases For November
Avi Kapoor
Milestone Pharmaceuticals shares are trading ...
Benzinga Newsdesk
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Milestone Pharmaceuticals Received An FDA Ref...
Benzinga Newsdesk
Monday, November 13, 2023
Recap: Milestone Pharmaceuticals Q3 Earnings
Benzinga Insights
Milestone Pharmaceuticals Q3 EPS $(0.35) Beat...
Benzinga Newsdesk
Sunday, November 12, 2023
Milestone Pharmaceuticals Announced Saturday: Results from ReVeRA Phase 2 Study of Etripamil in AFib-RVR Showed Statistically Significant Reduction In Ventricular Rate By 30 Beats Per Minute For Episodes Of Atrial Fibrillation With Rapid Ventricular Rate
Charles Gross
Tuesday, October 24, 2023
Milestone Pharmaceuticals Reports Submission ...
Benzinga Newsdesk
Wednesday, September 27, 2023
Milestone Pharmaceuticals Announces Etripamil...
Benzinga Newsdesk
Monday, August 14, 2023
HC Wainwright & Co. Reiterates Buy on Milesto...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch